1
INTRODUCTION Gingko Biloba one of the most widely used plant-based medicinal products primarily for treatment of a multitude of cognitive deficiencies. Systematic review of eight RCTs was conducted, examining the effect of GBE on coagulating factors. Blood coagulation is a clotting mechanism involving a cascade of reactions in which clotting factors are activated. GBE has been thought to have a positive effect on blood flow, blood viscosity, fibrinogen concentration, prothrombin time (PT) and activated partial thromboplastin time (aPTT) in response to bleeding. However, research studies showed no conclusive differences between baseline and treatments, with some showing insignificant positive results. ABSTRACT Blood coagulation is a highly regulated pathway dependent on multiple clotting factors. Gingko Biloba Extract (GBE) has been believed to reduce blood clot formation. 8 RCTs were systematically reviewed to examine the impact of GBE on coagulation. Contrary to belief, results were found to be inconclusive. DISCUSSION Review of studies revealed a lack of power calculations, comparison of dropouts to completers as well as blinding of patients and outcome assessors, hence failing to control potential bias. A possibility for discrepancy between results can be attributed to lack of significant number of participants in studies. Furthermore, indicated variation of GB dosage, ACKNOWLEDGEMENTS Special thanks to Dr. Betsy Singh for all your hard work and dedication towards your students. MATERIALS & METHODS Pubmed, EBSCOhost, and MedLine databases were searched between for articles 1980 to 2014. The following keywords were used to asses outcome parameters of hemostasis: Ginkgo Biloba Extract, GBE 761, coagulation, platelet aggregation, blood flow. The search of the 3 databases identified 25 unique references. Of the 25 potentially relevant studies, 10 nonhuman studies and 7 non-RCT studies were eliminated. Our analysis is based on 8 RCTs chosen for keyword relevance to Ginkgo biloba and blood coagulation. RESULTS Eight RCTs with a total of 455 individuals of mean age 36 were recruited from all studies. Half of the studies reviewed used standardized GBE 761 where as the remainder of the studies used standardized GB doses ranging from 120mg-360mg. Administrations methods were uncontrolled in 5 out of the 8 studies reviewed. 3 studies ensured that all biases were removed when administering treatments. 2 of the studies showed a positive correlation between treatment with GBE and inhibition of platelet aggregation as well as reduction of blood viscosity respectively. Remainder of studies showed no significant correlation. Analysis of RCTs failed to identify any statistically significant increase in blood flow with GBE compared to baseline measures and placebo groups. All eight studies showed no significant Effects of Gingko Biloba on Bleeding Times and Coagulation: A Systematic Review of Randomized Control Trials (RCTs) Sahin, Emir; Malik, Zamaar; Gomez, Andrew; Lanka, Padmavati; Elahi, Arooj; Singh, Betsy B. CONCLUSION In summary, all of the studies reviewed showed no significant difference between baseline measures and treatment groups for bleeding time and coagulation. No indication of higher bleeding risk. Author Title Total Kim, BH (2010) Influence of Ginkgo biloba Extract on the Pharmacodynamic Effects and Pharmacokinetic Properties of Ticlopidine: An Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single-Dose Crossover Study in Healthy Korean Male Volunteers 19/26 Bal dit Sollier, J (2003) No Alteration in Platelet Function or Coagulation Induced by EGb761 in a Controlled Study 17/26 Kudolo, GB (2004) The Ingestion of Ginkgo biloba Extract (EGb 761) Inhibits Arachidonic Acid-Mediated Platelet Aggregation 20/26 Kohler, S (2004) Influence of a 7-Day Treatment with Ginkgo Biloba Special Extract EGb 761 on Bleeding Time and Coagulation: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers 22/26 Galduro, JCF (2007) Gender- and Age-Related Variations in Blood Viscosity in Normal Volunteers: A Study of the Effects of Extract of Allium Sativum and Ginkgo Biloba 19/26 Carlson, JJ (2007) Safety and Efficacy of a Ginkgo BilobaContaining Dietary Supplement on Cognitive Function, Quality of Life, and Platelet Function in Healthy, Cognitively Intact OlderAdults 22/26 Kim, SH (2005) Effects of Ginkgo Biloba on Haemostatic Factors and Inflammation in Chronic Peritoneal Dialysis Patients 20/26

Ebm poster gb and coagulation final

Embed Size (px)

Citation preview

Slide 1

INTRODUCTIONGingko Biloba one of the most widely used plant-based medicinal products primarily for treatment of a multitude of cognitive deficiencies. Systematic review of eight RCTs was conducted, examining the effect of GBE on coagulating factors. Blood coagulation is a clotting mechanism involving a cascade of reactions in which clotting factors are activated. GBE has been thought to have a positive effect on blood flow, blood viscosity, fibrinogen concentration, prothrombin time (PT) and activated partial thromboplastin time (aPTT) in response to bleeding. However, research studies showed no conclusive differences between baseline and treatments, with some showing insignificant positive results.

ABSTRACTBlood coagulation is a highly regulated pathway dependent on multiple clotting factors. Gingko Biloba Extract (GBE) has been believed to reduce blood clot formation. 8 RCTs were systematically reviewed to examine the impact of GBE on coagulation. Contrary to belief, results were found to be inconclusive.DISCUSSIONReview of studies revealed a lack of power calculations, comparison of dropouts to completers as well as blinding of patients and outcome assessors, hence failing to control potential bias.

A possibility for discrepancy between results can be attributed to lack of significant number of participants in studies. Furthermore, indicated variation of GB dosage, method of administration, and diet.

ACKNOWLEDGEMENTS

Special thanks to Dr. Betsy Singh for all your hard work and dedication towards your students. MATERIALS & METHODS

Pubmed, EBSCOhost, and MedLine databases were searched between for articles 1980 to 2014. The following keywords were used to asses outcome parameters of hemostasis: Ginkgo Biloba Extract, GBE 761, coagulation, platelet aggregation, blood flow.

The search of the 3 databases identified 25 unique references. Of the 25 potentially relevant studies, 10 nonhuman studies and 7 non-RCT studies were eliminated. Our analysis is based on 8 RCTs chosen for keyword relevance to Ginkgo biloba and blood coagulation.

RESULTSEight RCTs with a total of 455 individuals of mean age 36 were recruited from all studies. Half of the studies reviewed used standardized GBE 761 where as the remainder of the studies used standardized GB doses ranging from 120mg-360mg. Administrations methods were uncontrolled in 5 out of the 8 studies reviewed. 3 studies ensured that all biases were removed when administering treatments. 2 of the studies showed a positive correlation between treatment with GBE and inhibition of platelet aggregation as well as reduction of blood viscosity respectively. Remainder of studies showed no significant correlation.

Analysis of RCTs failed to identify any statistically significant increase in blood flow with GBE compared to baseline measures and placebo groups. All eight studies showed no significant increase in blood flow. Effects of Gingko Biloba on Bleeding Times and Coagulation: A Systematic Review of Randomized Control Trials (RCTs)Sahin, Emir; Malik, Zamaar; Gomez, Andrew; Lanka, Padmavati; Elahi, Arooj; Singh, Betsy B.CONCLUSIONIn summary, all of the studies reviewed showed no significant difference between baseline measures and treatment groups for bleeding time and coagulation. No indication of higher bleeding risk.AuthorTitleTotalKim, BH (2010) Influence of Ginkgo biloba Extract on the Pharmacodynamic Effects and Pharmacokinetic Properties of Ticlopidine: An Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single-Dose Crossover Study in Healthy Korean Male Volunteers19/26Bal dit Sollier, J (2003)No Alteration in Platelet Function or Coagulation Induced by EGb761 in a Controlled Study17/26Kudolo, GB (2004)The Ingestion of Ginkgo biloba Extract (EGb 761) Inhibits Arachidonic Acid-Mediated Platelet Aggregation20/26Kohler, S (2004) Influence of a 7-Day Treatment with Ginkgo Biloba Special Extract EGb 761 on Bleeding Time and Coagulation: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers 22/26Galduro, JCF (2007)Gender- and Age-Related Variations in Blood Viscosity in Normal Volunteers: A Study of the Effects of Extract of Allium Sativum and Ginkgo Biloba19/26Carlson, JJ (2007) Safety and Efficacy of a Ginkgo BilobaContaining Dietary Supplement on Cognitive Function, Quality of Life, and Platelet Function in Healthy, Cognitively Intact OlderAdults22/26Kim, SH (2005)Effects of Ginkgo Biloba on Haemostatic Factors and Inflammation in Chronic Peritoneal Dialysis Patients20/26

Mehlsen, J (2002)Effects of a Ginkgo Biloba Extract on Forearm Haemodynamics in Healthy Volunteers17/26